Abstract
In this manuscript, three-dimensional quantitative structure-activity relationship (3D-QSAR) studies using comparative molecule field analysis (CoMFA) techniques were applied to provide the structural information of Bcl-2 inhibitors. The CoMFA model obtained from the training set were all statistically significant with the cross-validated coefficients (q2) of 0.568 and conventional coefficients (r2) of 0.991. The contribution of steric field and the electrostatic field is 0.635 and 0.365, respectively. The 3D-QSAR model was furthermore validated by a test set of 6 molecules. The predicted correlation coefficient (r2 pred) on the test set is 0.582. Therefore, the 3D-QSAR models built may be used to exhibit the necessary ligand-based structural environment as well as to design novel Bcl-2 inhibitors with increasing activities.
Keywords: CoMFA, Bcl-2 protein, inhibitors, 3D-QSAR, Comparative Molecular Field Analysis, GPCRs, Sketch Molecule, Gasteiger-Huckel, Partial Least Square, r2pred, HMLP, electrostatic field, leave-one-out, Tripos force fieldCoMFA, Bcl-2 protein, inhibitors, 3D-QSAR, Comparative Molecular Field Analysis, GPCRs, Sketch Molecule, Gasteiger-Huckel, Partial Least Square, r2pred, HMLP, electrostatic field, leave-one-out, Tripos force field
Protein & Peptide Letters
Title: 3D-QSAR Study on a Series of Bcl-2 Protein Inhibitors Using Comparative Molecular Field Analysis
Volume: 18 Issue: 5
Author(s): Xuben Hou, Jintong Du, Hao Fang and Minyong Li
Affiliation:
Keywords: CoMFA, Bcl-2 protein, inhibitors, 3D-QSAR, Comparative Molecular Field Analysis, GPCRs, Sketch Molecule, Gasteiger-Huckel, Partial Least Square, r2pred, HMLP, electrostatic field, leave-one-out, Tripos force fieldCoMFA, Bcl-2 protein, inhibitors, 3D-QSAR, Comparative Molecular Field Analysis, GPCRs, Sketch Molecule, Gasteiger-Huckel, Partial Least Square, r2pred, HMLP, electrostatic field, leave-one-out, Tripos force field
Abstract: In this manuscript, three-dimensional quantitative structure-activity relationship (3D-QSAR) studies using comparative molecule field analysis (CoMFA) techniques were applied to provide the structural information of Bcl-2 inhibitors. The CoMFA model obtained from the training set were all statistically significant with the cross-validated coefficients (q2) of 0.568 and conventional coefficients (r2) of 0.991. The contribution of steric field and the electrostatic field is 0.635 and 0.365, respectively. The 3D-QSAR model was furthermore validated by a test set of 6 molecules. The predicted correlation coefficient (r2 pred) on the test set is 0.582. Therefore, the 3D-QSAR models built may be used to exhibit the necessary ligand-based structural environment as well as to design novel Bcl-2 inhibitors with increasing activities.
Export Options
About this article
Cite this article as:
Hou Xuben, Du Jintong, Fang Hao and Li Minyong, 3D-QSAR Study on a Series of Bcl-2 Protein Inhibitors Using Comparative Molecular Field Analysis, Protein & Peptide Letters 2011; 18 (5) . https://dx.doi.org/10.2174/092986611794927992
DOI https://dx.doi.org/10.2174/092986611794927992 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Short Review of Analytical Methods for the Determination of Estramustine Phosphate and its Metabolites in Biological Samples
Current Pharmaceutical Analysis Current Targeting Strategies for Adenovirus Vectors in Cancer Gene Therapy
Current Cancer Drug Targets Study of Parasitic Infections, Cancer, and other Diseases with Mass-Spectrometry and Quantitative Proteome-Disease Relationships
Current Proteomics Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy
Mini-Reviews in Medicinal Chemistry P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism
Current Pharmaceutical Biotechnology Silybin and Silymarin - New and Emerging Applications in Medicine
Current Medicinal Chemistry Phytoecdysteroids - From Isolation to Their Effects on Humans
Current Medicinal Chemistry A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Current Pharmaceutical Design ADAM Metalloproteinases as Potential Drug Targets
Current Medicinal Chemistry Targeting Epigenetic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry A Newly Synthetized Ferrocenyl Derivative Selectively Induces Apoptosis in ALL Lymphocytes through Mitochondrial Estrogen Receptors
Anti-Cancer Agents in Medicinal Chemistry Indometacin Ameliorates High Glucose-Induced Proliferation and Invasion Via Modulation of E-Cadherin in Pancreatic Cancer Cells
Current Medicinal Chemistry USP48 Sustains Chemoresistance and Metastasis in Ovarian Cancer
Current Cancer Drug Targets CD44 and EpCAM: Cancer-Initiating Cell Markers
Current Molecular Medicine Novel Mechanisms of Anticancer Activities of Green Tea Component Epigallocatechin- 3-Gallate
Anti-Cancer Agents in Medicinal Chemistry Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer
Current Cancer Therapy Reviews ACO Inspired Computer-aided Detection/Diagnosis (CADe/CADx) Model for Medical Data Classification
Recent Patents on Computer Science Insights into the Platelet Releasate
Current Pharmaceutical Design Editorial (Hot Topic: Anti-cancer Molecular Targets of Natural Products)
Current Cancer Drug Targets